Raya Therapeutic Announces 9 Orphan Drug Designations Across its 5 Clinical Stage Compounds
The orphan drug designations (ODDs) are from both the FDA & EMA and for the treatment of Amyotrophic Lateral Sclerosis (ALS) & other neurodegenerative diseases. MONTREAL, QUEBEC, CANADA, January 9, 2025 /EINPresswire.com/ -- Raya …